Randomized trials - Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centers. RSD [Internet]. 2022 Jun. 21 [cited 2026 Jan. 2];11(8):e35511830844. Available from: https://rsdjournal.org/rsd/article/view/30844